Senegal-made sickle cell treatment raises hopes, reduces costs
Health
Business
September 18, 2026
Share this article
Click to view full size
DAKAR, Senegal (AFP) ā Mamadou Tahirou is 18 but looks more like a 12-year-old, his frame frail from the ravages of sickle cell disease, which one Senegalese laboratory is hoping to attenuate with affordable drug production.
The lab is one of the few in Africa producing generic hydroxyurea, the gold standard in sickle cell treatment, and the first ever in Senegal.
Speaking to AFP from his family home near Dakar, Tahirou, eyes bulging and features marked by fatigue, described a life dictated by the hereditary disease, which affects nearly eight million people worldwide.
Health
Business
Need the bigger picture?
Share this article
Comments (0)
Download our mobile app
The portable companion to gazettE. Get notifications, track read articles, and more. The latest news from Trinidad and Tobago, in one place.
